On Monday, Swift Transportation Company (NYSE:SWFT)’s shares declined -1.33%, and closed at $25.26, as Swift Transportation, will release its earnings for the first quarter ended March 31, 2015 after market close on Monday, April 27, 2015 in the form of a letter to stockholders. The letter will be published on the corporation’s website at http://investor.swifttrans.com/, in addition to filed with the SEC on a form 8-K.
A conference call is planned for Tuesday, April 28, 2015 at 10:00 a.m. EDT, where Swift Transportation’s administration team will answer questions formerly presented.
Swift Transportation Company operates as a multi-faceted transportation services corporation in North America. The corporation operates through four segments: Truckload, Dedicated, Central Refrigerated, and Intermodal. The Truckload segment provides services through one-way movements over irregular routes utilizing corporation’s and owner-operator tractors with dry van, flatbed, and specialized trailing equipment.
Plains GP Holdings, L.P. (NYSE:PAGP)’s shares dropped -1.32%, and settled at $27.56, during the last trading session on Monday, as Plains All American Pipeline, L.P. (NYSE:PAA) and Plains GP Holdings (NYSE:PAGP) declared they will release first-quarter 2015 earnings after market close on Tuesday, May 5, 2015, and will hold the following joint webcast and conference call.
Plains GP Holdings, L.P., through its interest in Plains AAP, L.P., owns and operates midstream energy infrastructure and provides logistics services for crude oil, natural gas liquids, natural gas, and refined products in the United States and Canada.
At the end of Monday’s trade, Celgene Corporation (NASDAQ:CELG)’s shares dipped -1.17%, and closed at $112.97, as Celgene will host a conference call and live audio webcast on Thursday, April 30, 2015 at 9 a.m. ET to talk about first quarter 2015 financial and operational results. The webcast can be accessed from the Investor Relations page at www.celgene.com.
Celgene Corporation, a biopharmaceutical corporation, discovers, develops, and commercializes therapies to treat cancer and inflammatory diseases in the United States and Internationally. It markets REVLIMID, an oral immunomodulatory drug for multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma; ABRAXANE, a solvent-free chemotherapy product to treat breast, non-small cell lung, pancreatic, and gastric cancers; POMALYST/IMNOVID for the treatment of multiple myeloma; and VIDAZA, a pyrimidine nucleoside analog to treat intermediate-2 and high-risk MDS, and chronic myelomonocytic leukemia, in addition to acute myeloid leukemia (AML).
Delta Air Lines, Inc. (NYSE:DAL), ended its Monday’s trading session with -1.16% loss, and closed at $41.76, after the news that Delta Air Lines, will continue expanding its network in Latin America with service from its largest hub in Atlanta to Medellin and Cartagena, Colombia starting Dec. 19, 2015.
Subject to government approval, the new flights complement Delta’s nonstop service from Bogota to Atlanta and New York. The new ATL-MDE route will operate using 124-seat Boeing 737-700 aircraft, and the ATL-CTG service will operate using 160-seat Boeing 737-800 aircraft.
The route between Atlanta and Medellin will provide customers one-stop access to more than 200 destinations from Delta’s largest hub, counting key business destinations in Europe like London, Madrid, Paris and more. The Atlanta-Cartagena route presents customers with access to the Colombian Caribbean and its unique coastal cities.
Customers traveling to and from Medellin and Cartagena will benefit from an improved experience at the Maynard H. Jackson International Terminal at Hartsfield-Jackson Atlanta International Airport, which features full Spanish signage throughout the airport. From the state-of-the-art terminal, travelers have access to Delta’s more than 900 peak-day flights, counting nonstop service to 62 international destinations.
Delta Air Lines, Inc. provides planned air transportation for passengers and cargo worldwide. The corporation operates in two segments, Airline and Refinery. Its route network comprises various gateway airports in Amsterdam, Detroit, Los Angeles, Minneapolis-St. Paul, New York-LaGuardia, New York-JFK, Paris-Charles de Gaulle, Salt Lake City, Seattle, and Tokyo-Narita.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
